General information about company

Scrip code*540204
NSE Symbol*NOTLISTED
MSEI Symbol*NOTLISTED
ISIN*INE666Q01016
Name of companyEiko Lifesciences Ltd
Type of companyMain Board
Class of securityEquity
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Date of board meeting when results were approved29-07-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange24-07-2025
Description of presentation currencyINR
Level of roundingLakhs
Reporting TypeQuarterly
Reporting QuarterFirst quarter
Nature of report standalone or consolidatedConsolidated
Whether results are audited or unaudited for the quarter endedUnaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment ReportingMulti segment
Description of single segment
Start date and time of board meeting29-07-2025 18:00
End date and time of board meeting29-07-2025 19:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualificationNot applicable



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-04-202501-04-2025
Date of end of reporting period30-06-202530-06-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations1071.151071.15
Other income26.5226.52
Total income1097.671097.67
2Expenses
(a)Cost of materials consumed545.83545.83
(b)Purchases of stock-in-trade00
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade284.31284.31
(d)Employee benefit expense 12.5612.56
(e)Finance costs4.824.82
(f)Depreciation, depletion and amortisation expense25.3725.37
(g)Other Expenses
1Other Expenses77.3377.33
Total other expenses77.3377.33
Total expenses950.22950.22
3Total profit before exceptional items and tax147.45147.45
4Exceptional items 00
5Total profit before tax147.45147.45
6Tax expense
7Current tax29.9929.99
8Deferred tax6.786.78
9Total tax expenses36.7736.77
10Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
11Net Profit Loss for the period from continuing operations110.68110.68
12Profit (loss) from discontinued operations before tax00
13Tax expense of discontinued operations00
14Net profit (loss) from discontinued operation after tax00
15Share of profit (loss) of associates and joint ventures accounted for using equity method1.061.06
16Total profit (loss) for period111.74111.74
17Other comprehensive income net of taxes00
18Total Comprehensive Income for the period111.74111.74
19Total profit or loss, attributable to
Profit or loss, attributable to owners of parent91.4291.42
Total profit or loss, attributable to non-controlling interests20.3120.31
20Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent00
Total comprehensive income for the period attributable to owners of parent non-controlling interests00
21Details of equity share capital
Paid-up equity share capital1376.271376.27
Face value of equity share capital1010
22Reserves excluding revaluation reserve
23Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations0.660.66
Diluted earnings (loss) per share from continuing operations0.660.66
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiiEarnings per equity share (for continuing and discontinued operations)
Basic earnings (loss) per share from continuing and discontinued operations0.660.66
Diluted earnings (loss) per share from continuing and discontinued operations0.660.66
24Debt equity ratioTextual Information( 1)
25Debt service coverage ratioTextual Information( 2)
26Interest service coverage ratioTextual Information( 3)
27Disclosure of notes on financial resultsTextual Information(4)

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars3 months/ 6 month ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-04-202501-04-2025
Date of end of reporting period30-06-202530-06-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
1Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1Specialty & Fine Chemicals840.22840.22
2Logistics Business230.93230.93
Total Segment Revenue1071.151071.15
Less: Inter segment revenue
Revenue from operations 1071.151071.15
2Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1Specialty & Fine Chemicals44.4244.42
2Logistics Business29.7329.73
Total Profit before tax74.1574.15
i. Finance cost4.824.82
ii. Other Unallocable Expenditure net off Unallocable income-79.17-79.17
Profit before tax148.5148.5
3(Segment Asset - Segment Liabilities)
Segment Asset
1Specialty & Fine Chemicals3781.523781.52
2Logistics Business1073.791073.79
Total Segment Asset4855.314855.31
Un-allocable Assets1567.191567.19
Net Segment Asset6422.56422.5
4Segment Liabilities
Segment Liabilities
1Specialty & Fine Chemicals435.79435.79
2Logistics Business154.64154.64
Total Segment Liabilities590.43590.43
Un-allocable Liabilities00
Net Segment Liabilities590.43590.43
Disclosure of notes on segments

Other Comprehensive Income

Date of start of reporting period01-04-202501-04-2025
Date of end of reporting period30-06-202530-06-2025
Whether results are audited or unauditedUnauditedUnaudited
Nature of report standalone or consolidatedConsolidatedConsolidated
Other comprehensive income [Abstract]
1Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2Income tax relating to items that will not be reclassified to profit or loss 0.000.00
3Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4Income tax relating to items that will be reclassified to profit or loss 0.000.00
5Total Other comprehensive income0.000.00